1 Angina Pectoris Treatment Market Overview 1.1 Product Overview and Scope of Angina Pectoris Treatment 1.2 Angina Pectoris Treatment Segment by Type 1.2.1 Global Angina Pectoris Treatment Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Antiplatelet agents 1.2.3 Beta-adrenergic blocking agents 1.2.4 Calcium channel blockers 1.2.5 Short & Long – acting Nitroglycerines 1.2.6 Angiotensin-converting enzyme (ACE) inhibitors 1.2.7 Anti-ischemic agents 1.3 Angina Pectoris Treatment Segment by Application 1.3.1 Angina Pectoris Treatment Sales Comparison by Application: (2021-2027) 1.3.2 Hospitals 1.3.3 Clinic 1.3.4 Other 1.4 Global Angina Pectoris Treatment Market Size Estimates and Forecasts 1.4.1 Global Angina Pectoris Treatment Revenue 2016-2027 1.4.2 Global Angina Pectoris Treatment Sales 2016-2027 1.4.3 Angina Pectoris Treatment Market Size by Region: 2016 Versus 2021 Versus 2027 2 Angina Pectoris Treatment Market Competition by Manufacturers 2.1 Global Angina Pectoris Treatment Sales Market Share by Manufacturers (2016-2021) 2.2 Global Angina Pectoris Treatment Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Angina Pectoris Treatment Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Angina Pectoris Treatment Manufacturing Sites, Area Served, Product Type 2.5 Angina Pectoris Treatment Market Competitive Situation and Trends 2.5.1 Angina Pectoris Treatment Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Angina Pectoris Treatment Players Market Share by Revenue 2.5.3 Global Angina Pectoris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Angina Pectoris Treatment Retrospective Market Scenario by Region 3.1 Global Angina Pectoris Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Angina Pectoris Treatment Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Angina Pectoris Treatment Market Facts & Figures by Country 3.3.1 North America Angina Pectoris Treatment Sales by Country 3.3.2 North America Angina Pectoris Treatment Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Angina Pectoris Treatment Market Facts & Figures by Country 3.4.1 Europe Angina Pectoris Treatment Sales by Country 3.4.2 Europe Angina Pectoris Treatment Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Angina Pectoris Treatment Market Facts & Figures by Region 3.5.1 Asia Pacific Angina Pectoris Treatment Sales by Region 3.5.2 Asia Pacific Angina Pectoris Treatment Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Angina Pectoris Treatment Market Facts & Figures by Country 3.6.1 Latin America Angina Pectoris Treatment Sales by Country 3.6.2 Latin America Angina Pectoris Treatment Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Angina Pectoris Treatment Market Facts & Figures by Country 3.7.1 Middle East and Africa Angina Pectoris Treatment Sales by Country 3.7.2 Middle East and Africa Angina Pectoris Treatment Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Angina Pectoris Treatment Historic Market Analysis by Type 4.1 Global Angina Pectoris Treatment Sales Market Share by Type (2016-2021) 4.2 Global Angina Pectoris Treatment Revenue Market Share by Type (2016-2021) 4.3 Global Angina Pectoris Treatment Price by Type (2016-2021) 5 Global Angina Pectoris Treatment Historic Market Analysis by Application 5.1 Global Angina Pectoris Treatment Sales Market Share by Application (2016-2021) 5.2 Global Angina Pectoris Treatment Revenue Market Share by Application (2016-2021) 5.3 Global Angina Pectoris Treatment Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Abbott Laboratories Inc. 6.1.1 Abbott Laboratories Inc. Corporation Information 6.1.2 Abbott Laboratories Inc. Description and Business Overview 6.1.3 Abbott Laboratories Inc. Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Abbott Laboratories Inc. Product Portfolio 6.1.5 Abbott Laboratories Inc. Recent Developments/Updates 6.2 Astra Zeneca plc 6.2.1 Astra Zeneca plc Corporation Information 6.2.2 Astra Zeneca plc Description and Business Overview 6.2.3 Astra Zeneca plc Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Astra Zeneca plc Product Portfolio 6.2.5 Astra Zeneca plc Recent Developments/Updates 6.3 Bayer AG 6.3.1 Bayer AG Corporation Information 6.3.2 Bayer AG Description and Business Overview 6.3.3 Bayer AG Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Bayer AG Product Portfolio 6.3.5 Bayer AG Recent Developments/Updates 6.4 Bristol-Myers Squibb Company 6.4.1 Bristol-Myers Squibb Company Corporation Information 6.4.2 Bristol-Myers Squibb Company Description and Business Overview 6.4.3 Bristol-Myers Squibb Company Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Bristol-Myers Squibb Company Product Portfolio 6.4.5 Bristol-Myers Squibb Company Recent Developments/Updates 6.5 F. Hoffmann-La Roche Ltd 6.5.1 F. Hoffmann-La Roche Ltd Corporation Information 6.5.2 F. Hoffmann-La Roche Ltd Description and Business Overview 6.5.3 F. Hoffmann-La Roche Ltd Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.5.4 F. Hoffmann-La Roche Ltd Product Portfolio 6.5.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates 6.6 Forest Laboratories Inc 6.6.1 Forest Laboratories Inc Corporation Information 6.6.2 Forest Laboratories Inc Description and Business Overview 6.6.3 Forest Laboratories Inc Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Forest Laboratories Inc Product Portfolio 6.6.5 Forest Laboratories Inc Recent Developments/Updates 6.7 Gilead Sciences, Inc 6.6.1 Gilead Sciences, Inc Corporation Information 6.6.2 Gilead Sciences, Inc Description and Business Overview 6.6.3 Gilead Sciences, Inc Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Gilead Sciences, Inc Product Portfolio 6.7.5 Gilead Sciences, Inc Recent Developments/Updates 6.8 GlaxoSmithKline plc 6.8.1 GlaxoSmithKline plc Corporation Information 6.8.2 GlaxoSmithKline plc Description and Business Overview 6.8.3 GlaxoSmithKline plc Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.8.4 GlaxoSmithKline plc Product Portfolio 6.8.5 GlaxoSmithKline plc Recent Developments/Updates 6.9 Novartis AG 6.9.1 Novartis AG Corporation Information 6.9.2 Novartis AG Description and Business Overview 6.9.3 Novartis AG Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Novartis AG Product Portfolio 6.9.5 Novartis AG Recent Developments/Updates 6.10 Pfizer Inc. 6.10.1 Pfizer Inc. Corporation Information 6.10.2 Pfizer Inc. Description and Business Overview 6.10.3 Pfizer Inc. Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Pfizer Inc. Product Portfolio 6.10.5 Pfizer Inc. Recent Developments/Updates 6.11 Sanofi SA 6.11.1 Sanofi SA Corporation Information 6.11.2 Sanofi SA Angina Pectoris Treatment Description and Business Overview 6.11.3 Sanofi SA Angina Pectoris Treatment Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Sanofi SA Product Portfolio 6.11.5 Sanofi SA Recent Developments/Updates 7 Angina Pectoris Treatment Manufacturing Cost Analysis 7.1 Angina Pectoris Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Angina Pectoris Treatment 7.4 Angina Pectoris Treatment Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Angina Pectoris Treatment Distributors List 8.3 Angina Pectoris Treatment Customers 9 Angina Pectoris Treatment Market Dynamics 9.1 Angina Pectoris Treatment Industry Trends 9.2 Angina Pectoris Treatment Growth Drivers 9.3 Angina Pectoris Treatment Market Challenges 9.4 Angina Pectoris Treatment Market Restraints 10 Global Market Forecast 10.1 Angina Pectoris Treatment Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Angina Pectoris Treatment by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Angina Pectoris Treatment by Type (2022-2027) 10.2 Angina Pectoris Treatment Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Angina Pectoris Treatment by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Angina Pectoris Treatment by Application (2022-2027) 10.3 Angina Pectoris Treatment Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Angina Pectoris Treatment by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Angina Pectoris Treatment by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Angina Pectoris Treatment Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Angina Pectoris Treatment Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Angina Pectoris Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Angina Pectoris Treatment Covered in This Study Table 5. Global Angina Pectoris Treatment Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Angina Pectoris Treatment Sales Share by Manufacturers (2016-2021) Table 7. Global Angina Pectoris Treatment Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Angina Pectoris Treatment Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Angina Pectoris Treatment Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Angina Pectoris Treatment Manufacturing Sites and Area Served Table 11. Manufacturers Angina Pectoris Treatment Product Type Table 12. Global Angina Pectoris Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Angina Pectoris Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angina Pectoris Treatment as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Angina Pectoris Treatment Sales by Region (2016-2021) & (K Pcs) Table 16. Global Angina Pectoris Treatment Sales Market Share by Region (2016-2021) Table 17. Global Angina Pectoris Treatment Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Angina Pectoris Treatment Sales by Country (2016-2021) & (K Pcs) Table 19. North America Angina Pectoris Treatment Sales Market Share by Country (2016-2021) Table 20. North America Angina Pectoris Treatment Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Angina Pectoris Treatment Revenue Market Share by Country (2016-2021) Table 22. Europe Angina Pectoris Treatment Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Angina Pectoris Treatment Sales Market Share by Country (2016-2021) Table 24. Europe Angina Pectoris Treatment Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Angina Pectoris Treatment Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Angina Pectoris Treatment Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Angina Pectoris Treatment Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Angina Pectoris Treatment Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Angina Pectoris Treatment Revenue Market Share by Region (2016-2021) Table 30. Latin America Angina Pectoris Treatment Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Angina Pectoris Treatment Sales Market Share by Country (2016-2021) Table 32. Latin America Angina Pectoris Treatment Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Angina Pectoris Treatment Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Angina Pectoris Treatment Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Angina Pectoris Treatment Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Angina Pectoris Treatment Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Angina Pectoris Treatment Revenue Market Share by Country (2016-2021) Table 38. Global Angina Pectoris Treatment Sales (K Pcs) by Type (2016-2021) Table 39. Global Angina Pectoris Treatment Sales Market Share by Type (2016-2021) Table 40. Global Angina Pectoris Treatment Revenue (Million US$) by Type (2016-2021) Table 41. Global Angina Pectoris Treatment Revenue Share by Type (2016-2021) Table 42. Global Angina Pectoris Treatment Price (USD/Pcs) by Type (2016-2021) Table 43. Global Angina Pectoris Treatment Sales (K Pcs) by Application (2016-2021) Table 44. Global Angina Pectoris Treatment Sales Market Share by Application (2016-2021) Table 45. Global Angina Pectoris Treatment Revenue (Million US$) by Application (2016-2021) Table 46. Global Angina Pectoris Treatment Revenue Share by Application (2016-2021) Table 47. Global Angina Pectoris Treatment Price (USD/Pcs) by Application (2016-2021) Table 48. Abbott Laboratories Inc. Corporation Information Table 49. Abbott Laboratories Inc. Description and Business Overview Table 50. Abbott Laboratories Inc. Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Abbott Laboratories Inc. Angina Pectoris Treatment Product Table 52. Abbott Laboratories Inc. Recent Developments/Updates Table 53. Astra Zeneca plc Corporation Information Table 54. Astra Zeneca plc Description and Business Overview Table 55. Astra Zeneca plc Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Astra Zeneca plc Angina Pectoris Treatment Product Table 57. Astra Zeneca plc Recent Developments/Updates Table 58. Bayer AG Corporation Information Table 59. Bayer AG Description and Business Overview Table 60. Bayer AG Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Bayer AG Angina Pectoris Treatment Product Table 62. Bayer AG Recent Developments/Updates Table 63. Bristol-Myers Squibb Company Corporation Information Table 64. Bristol-Myers Squibb Company Description and Business Overview Table 65. Bristol-Myers Squibb Company Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Bristol-Myers Squibb Company Angina Pectoris Treatment Product Table 67. Bristol-Myers Squibb Company Recent Developments/Updates Table 68. F. Hoffmann-La Roche Ltd Corporation Information Table 69. F. Hoffmann-La Roche Ltd Description and Business Overview Table 70. F. Hoffmann-La Roche Ltd Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. F. Hoffmann-La Roche Ltd Angina Pectoris Treatment Product Table 72. F. Hoffmann-La Roche Ltd Recent Developments/Updates Table 73. Forest Laboratories Inc Corporation Information Table 74. Forest Laboratories Inc Description and Business Overview Table 75. Forest Laboratories Inc Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. Forest Laboratories Inc Angina Pectoris Treatment Product Table 77. Forest Laboratories Inc Recent Developments/Updates Table 78. Gilead Sciences, Inc Corporation Information Table 79. Gilead Sciences, Inc Description and Business Overview Table 80. Gilead Sciences, Inc Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 81. Gilead Sciences, Inc Angina Pectoris Treatment Product Table 82. Gilead Sciences, Inc Recent Developments/Updates Table 83. GlaxoSmithKline plc Corporation Information Table 84. GlaxoSmithKline plc Description and Business Overview Table 85. GlaxoSmithKline plc Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 86. GlaxoSmithKline plc Angina Pectoris Treatment Product Table 87. GlaxoSmithKline plc Recent Developments/Updates Table 88. Novartis AG Corporation Information Table 89. Novartis AG Description and Business Overview Table 90. Novartis AG Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 91. Novartis AG Angina Pectoris Treatment Product Table 92. Novartis AG Recent Developments/Updates Table 93. Pfizer Inc. Corporation Information Table 94. Pfizer Inc. Description and Business Overview Table 95. Pfizer Inc. Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 96. Pfizer Inc. Angina Pectoris Treatment Product Table 97. Pfizer Inc. Recent Developments/Updates Table 98. Sanofi SA Corporation Information Table 99. Sanofi SA Description and Business Overview Table 100. Sanofi SA Angina Pectoris Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 101. Sanofi SA Angina Pectoris Treatment Product Table 102. Sanofi SA Recent Developments/Updates Table 103. Production Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Angina Pectoris Treatment Distributors List Table 106. Angina Pectoris Treatment Customers List Table 107. Angina Pectoris Treatment Market Trends Table 108. Angina Pectoris Treatment Growth Drivers Table 109. Angina Pectoris Treatment Market Restraints Table 110. Global Angina Pectoris Treatment Sales Forecast by Type (2022-2027) & (K Pcs) Table 111. Global Angina Pectoris Treatment Sales Market Share Forecast by Type (2022-2027) Table 112. Global Angina Pectoris Treatment Revenue Forecast by Type (2022-2027) & (US$ Million) Table 113. Global Angina Pectoris Treatment Revenue Market Share Forecast by Type (2022-2027) Table 114. Global Angina Pectoris Treatment Sales Forecast by Application (2022-2027) & (K Pcs) Table 115. Global Angina Pectoris Treatment Sales Market Share Forecast by Application (2022-2027) Table 116. Global Angina Pectoris Treatment Revenue Forecast by Application (2022-2027) & (US$ Million) Table 117. Global Angina Pectoris Treatment Revenue Market Share Forecast by Application (2022-2027) Table 118. Global Angina Pectoris Treatment Sales Forecast by Region (2022-2027) & (K Pcs) Table 119. Global Angina Pectoris Treatment Sales Market Share Forecast by Region (2022-2027) Table 120. Global Angina Pectoris Treatment Revenue Forecast by Region (2022-2027) & (US$ Million) Table 121. Global Angina Pectoris Treatment Revenue Market Share Forecast by Region (2022-2027) Table 122. Research Programs/Design for This Report Table 123. Key Data Information from Secondary Sources Table 124. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Angina Pectoris Treatment Figure 2. Global Angina Pectoris Treatment Market Share by Type in 2020 & 2027 Figure 3. Antiplatelet agents Product Picture Figure 4. Beta-adrenergic blocking agents Product Picture Figure 5. Calcium channel blockers Product Picture Figure 6. Short & Long – acting Nitroglycerines Product Picture Figure 7. Angiotensin-converting enzyme (ACE) inhibitors Product Picture Figure 8. Anti-ischemic agents Product Picture Figure 9. Global Angina Pectoris Treatment Market Share by Application in 2020 & 2027 Figure 10. Hospitals Figure 11. Clinic Figure 12. Other Figure 13. Global Angina Pectoris Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Angina Pectoris Treatment Market Size 2016-2027 (US$ Million) Figure 15. Global Angina Pectoris Treatment Sales 2016-2027 (K Pcs) Figure 16. Global Angina Pectoris Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Angina Pectoris Treatment Sales Share by Manufacturers in 2020 Figure 18. Global Angina Pectoris Treatment Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Angina Pectoris Treatment Players: Market Share by Revenue in 2020 Figure 20. Angina Pectoris Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Angina Pectoris Treatment Sales Market Share by Region (2016-2021) Figure 22. Global Angina Pectoris Treatment Sales Market Share by Region in 2020 Figure 23. Global Angina Pectoris Treatment Revenue Market Share by Region (2016-2021) Figure 24. Global Angina Pectoris Treatment Revenue Market Share by Region in 2020 Figure 25. U.S. Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. U.K. Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Taiwan Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Philippines Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Vietnam Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Mexico Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Brazil Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Argentina Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Turkey Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Saudi Arabia Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. U.A.E Angina Pectoris Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Sales Market Share of Angina Pectoris Treatment by Type (2016-2021) Figure 50. Sales Market Share of Angina Pectoris Treatment by Application (2016-2021) Figure 51. Sales Market Share of Angina Pectoris Treatment by Application in 2020 Figure 52. Revenue Share of Angina Pectoris Treatment by Application (2016-2021) Figure 53. Revenue Share of Angina Pectoris Treatment by Application in 2020 Figure 54. Manufacturing Cost Structure of Angina Pectoris Treatment Figure 55. Manufacturing Process Analysis of Angina Pectoris Treatment Figure 56. Angina Pectoris Treatment Industrial Chain Analysis Figure 57. Channels of Distribution Figure 58. Distributors Profiles Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

Abbott Laboratories Inc. Astra Zeneca plc Bayer AG Bristol-Myers Squibb Company F. Hoffmann-La Roche Ltd Forest Laboratories Inc Gilead Sciences, Inc GlaxoSmithKline plc Novartis AG Pfizer Inc. Sanofi SA